159 related articles for article (PubMed ID: 3274449)
1. Rescue of severe steroid-resistant rejection with OKT3.PAN.
Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
[No Abstract] [Full Text] [Related]
2. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.
Haberal M; Sert S; Gülay H; Arslan G; Bilgin N
Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801
[No Abstract] [Full Text] [Related]
3. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Blümke M; Kirste G; Wanner U; Wilms H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
[No Abstract] [Full Text] [Related]
4. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
5. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
[No Abstract] [Full Text] [Related]
6. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
7. Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period.
Hesse UJ; Wienand P; Baldamus C; Arns W
Transplant Proc; 1990 Oct; 22(5):2273-4. PubMed ID: 2120814
[No Abstract] [Full Text] [Related]
8. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
[No Abstract] [Full Text] [Related]
9. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
[No Abstract] [Full Text] [Related]
10. Histologic findings and kidney graft outcome in patients with steroid-resistant rejections before and after OKT3 therapy.
Niebel W; Metz KA; Albrecht KH; Wagner K; Kribben A; Erhard J; Eigler FW
Transplant Proc; 1990 Aug; 22(4):1764. PubMed ID: 2117802
[No Abstract] [Full Text] [Related]
11. Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.
Kahana L; Ackermann J; Lefor W; Weinstein S; Wright C; DeQuesada A; Alveranga D; Baxter J; Shires D
Transplant Proc; 1990 Aug; 22(4):1755-8. PubMed ID: 2117799
[TBL] [Abstract][Full Text] [Related]
12. Treatment with OKT3 and cyclosporine for acute allograft rejection.
Schulak JA; Mayes JT; Hricik DE
Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
[TBL] [Abstract][Full Text] [Related]
13. Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection.
Le Mauff B; Hourmant M; Le Meur Y; Dantal J; Cantarovich D; Caudrelier P; Alberici G; Soulillou JP
Transplant Proc; 1995 Feb; 27(1):865-6. PubMed ID: 7879210
[No Abstract] [Full Text] [Related]
14. Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation.
Welter HF; Illner WD; Schleibner S; Abendroth D; Hancke E; Groh J; Land W
Transplant Proc; 1990 Oct; 22(5):2272. PubMed ID: 2120813
[No Abstract] [Full Text] [Related]
15. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
Tellis VA; Matas AJ; Quinn TA; Glicklich D; Weiss RJ; Soberman RJ; Veith FJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
[No Abstract] [Full Text] [Related]
16. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
[No Abstract] [Full Text] [Related]
17. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
[No Abstract] [Full Text] [Related]
18. Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
Illner WD; Theodorakis J; Abendroth D; Schleibner S; Stangl M; Landgraf R; Land W
Transplant Proc; 1990 Aug; 22(4):1586-7. PubMed ID: 2117795
[No Abstract] [Full Text] [Related]
19. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.
De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C
Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800
[No Abstract] [Full Text] [Related]
20. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
Gonwa TA; Nghiem DD; Corry RJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
